NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina
National Institutes of Health (NIH) sent this bulletin at 12/16/2019 12:30 PM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
12/16/2019 11:45 AM EST
NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment.